Trial intelligence / Profile preview

Fospropofol Disodium for General Anesthesia Induction in Obese Patients

ChiCTR2500105833Phase 4Not yet recruiting

Sponsor
Gansu Provincial People's Hospital
Start
Jul 2025
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of fospropofol disodium in None (3 arms), sponsored by Gansu Provincial People's Hospital. Primary endpoint: Sedation success rate. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

fospropofol disodium

Beyond the preview

Go deeper on ChiCTR2500105833.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500105833.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call